Cardiovascular Events After COVID-19 Vaccination in Sweden
Author Information
Author(s): Yiyi Xu, Huiqi Li, Ailiana Santosa, Björn Wettermark, Tove Fall, Jonas Björk, Mats Börjesson, Magnus Gisslén, Fredrik Nyberg
Primary Institution: University of Gothenburg
Hypothesis
Does COVID-19 vaccination increase the risk of cardiovascular events in adults?
Conclusion
COVID-19 vaccination is associated with a transient increase in the risk of mild cardiovascular events but significantly reduces the risk of severe cardiovascular outcomes.
Supporting Evidence
- Vaccination reduces the risk of severe cardiovascular conditions.
- Transient increases in myocarditis and pericarditis were observed after vaccination.
- Decreased risks of myocardial infarction and heart failure were noted post-vaccination.
- Data was collected from a large, nationwide cohort of Swedish adults.
- Findings align with previous studies indicating protective effects of COVID-19 vaccination.
Takeaway
Getting vaccinated against COVID-19 might cause some temporary heart issues, but it helps prevent serious heart problems later on.
Methodology
Nationwide register-based cohort study assessing cardiovascular risks post-vaccination using Cox regression models.
Potential Biases
Possible survivor bias affecting the results for the third vaccine dose.
Limitations
Potential misclassification of COVID-19 infection and lack of data on primary care diagnoses.
Participant Demographics
Adults in Sweden aged 18 and older, with a median age of 48 years; 49.9% male and 50.1% female.
Statistical Information
Confidence Interval
95% CI reported for hazard ratios.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website